One of the scientists at LPU School of Pharmaceutical Sciences Miss Rubiya Khursheed has shared about her patented herbal medicine with 15 Nobel Laureates, 6000+ Scientists and 600+ Pharmacy Industry giants in America. The occasion was the world’s most prestigious pharmacy conference ‘AAPS 2019 PharmSci 360’, held at Henry B. Gonzalez Convention Center, San Antonio (Texas) in the USA. The scientific title of her work was “Exploring the role of Synbiotics as carrier to solidify Self-Nano emulsifying Drug Delivery System”. For this important sharing, Rubiya was awarded certificate of acknowledgement under the signatures of AAPS (American Association of Pharmaceutical Scientists) President Dr Dale Eric Wurster.
Rubiya also shares that the two important constituents of her medicine are easily available in the market- Haldi (Turmeric) and Friendly Bacteria (Pro-Biotics). To get the desired product, Rubiya enhanced the solubility of the two; made emulsion of these; and, increased the nature of their solubility for solidification and stability. For these processes, she preferred non-toxic matter. Prior to her product, the dosage that used to be was of 500mg, which has now come down to a mere 5 mg. Rubiya’s medicine, which is totally non-synthetic and without any of the side-effects, is to control deadly considered ‘Diabetes’ disease. Soon there will be the commercialization of this patented medicine for the general benefit of humanity.
Hailing from Bagh-e-Mehtab, Sri Nagar (J&K), PhD scholar at LPU; Rubiya wants to contribute much in the name of LPU, which guided her to see her work gets recognition on a prestigious international platform. She further wants to continue with her another important research on curing of cancer. She wants that all the medical formulations should be developed into very economical products so that all and sundry be able to use these in an easy manner.
In fact, as a professional association, AAPS aims to increase the capacity of pharmaceutical scientists to develop products and therapies that improve public health. Deeply interested in translational research, Rubiya too has a keen desire to develop formulations that could reach to the patients suffering from diabetes in an easy manner. Congratulating Rubiya for her socially useful product, LPU Chancellor Mr Ashok Mittal inspired her to continue to be research-oriented with such a temperament.
The conference was also witnessed by top pharmacy industries including Pfizer, Lupin, AstraZeneca, Biocon, Evonik, Bruker, Perkin Elmer. Her research work was well received and appreciated by the audience. Rubiya is currently working on the development of Nanocarriers for improving the oral bioavailability of probiotics under the supervision of Senior Dean Dr Monica Gulati and Dr Sachin Kumar at LPU. As a PhD Scholar at LPU, she has already published 9 important research papers in reputed international journals including ‘Drug Discovery Today’, ‘European Journal of Pharmacology’, ‘Journal of Drug Delivery Science and Technology and more.
